Health Condition 1: null- Patient scheduled for MIDCAB surgery under general anesthesia
Conditions
Interventions
Intervention1: SAP Group: It will receive 20 ml 0.2 % ropivacaine with 1 mcg/ml fentanyl as bolus in the serratus anterior plane followed by its infusion at a rate of 8 ml/hr in the post-operative per
Sponsors
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (35-65 yrs) of either sex, American society of Anesthesiologists (ASA) physical status I and II with New York Heart association (NYHA) grading I and II, scheduled for MIDCAB surgery under general anesthesia will be included in the study.
Exclusion criteria
Exclusion criteria: Patients with uncontrolled medical diseases, uncontrolled psychiatric ailments, coagulopathy, infection at the local site and patient refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pain during lying supine, deep inspiration, coughing and patient movementTimepoint: 6 hourly intervals for a period of 48 hrs starting from patient arrival in the intensive care unit | — |
Secondary
| Measure | Time frame |
|---|---|
| Requirement of post-operative intravenous (IV) fentanyl requirement, post-operative nausea and vomiting (PONV), requirement of rescue antiemetic, pruritis, respiratory depressionTimepoint: 6 hourly intervals for a period of 48 hrs starting from patient arrival in the intensive care unit | — |
Countries
India
Contacts
Public ContactSujeet Kumar Singh Gautam
Sanjay Gandhi Post-graduate Institute of Medical Sciences
Outcome results
None listed